Komal Jhaveri
- Oncology top 1%
- Pulmonary and Respiratory Medicine top 2%
- Radiology, Nuclear Medicine and Imaging top 2%
- Cancer Research top 5%
- Molecular Biology
- Co-authors
- Gary A. UlanerShanu ModiAditya BardiaFrancisco J. EstevaChristopher C. RiedlHope S. RugoFrederik MarméSara M. Tolaney
- Topics
- Advanced Breast Cancer Therapies (104 papers)HER2/EGFR in Cancer Research (75 papers)Cancer Treatment and Pharmacology (71 papers)
- Partner nations
- United StatesSpainUnited Kingdom
In The Last Decade
Komal Jhaveri
161 papers receiving 2.9k citations
Hit Papers
Peers
Comparison fields: 5 of 90
- Oncology 1.8k
- Pulmonary and Respiratory Medicine 1.2k
- Radiology, Nuclear Medicine and Imaging 888
- Cancer Research 639
- Molecular Biology 627
Countries citing papers authored by Komal Jhaveri
This map shows the geographic impact of Komal Jhaveri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Komal Jhaveri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Komal Jhaveri more than expected).
Fields of papers citing papers by Komal Jhaveri
This network shows the impact of papers produced by Komal Jhaveri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Komal Jhaveri. The network helps show where Komal Jhaveri may publish in the future.
Co-authorship network of co-authors of Komal Jhaveri
This figure shows the co-authorship network connecting the top 25 collaborators of Komal Jhaveri. A scholar is included among the top collaborators of Komal Jhaveri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Komal Jhaveri. Komal Jhaveri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 5 | |
| 2 | 1 | |
| 3 | 1 | |
| 4 | 3 | |
| 5 | 0 | |
| 6 | 1 | |
| 7 | 23 | |
| 8 | 1 | |
| 9 | 1 | |
| 10 | 1 | |
| 11 | 0 | |
| 12 | 9 | |
| 13 | 36 | |
| 14 | Sacituzumab Govitecan in Hormone Receptor–Positive/Human Epidermal Growth Factor Receptor 2–Negative Metastatic Breast Cancerbreakdown → | 176 |
| 15 | 14 | |
| 16 | 26 | |
| 17 | 45 | |
| 18 | 67 | |
| 19 | 141 | |
| 20 | 87 |
About Komal Jhaveri
Komal Jhaveri is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research, having authored 173 papers that have together received 2.9k indexed citations. Recurring topics across this work include Advanced Breast Cancer Therapies (104 papers), HER2/EGFR in Cancer Research (75 papers) and Cancer Treatment and Pharmacology (71 papers). The work is most often cited by research in Oncology (1.8k citations), Cancer Research (639 citations) and Radiology, Nuclear Medicine and Imaging (888 citations). Komal Jhaveri has collaborated with scholars based in United States, Spain and United Kingdom. Frequent co-authors include Gary A. Ulaner, Shanu Modi, Aditya Bardia, Francisco J. Esteva, Christopher C. Riedl, Hope S. Rugo, Frederik Marmé, Sara M. Tolaney, Sarat Chandarlapaty and Florence Dalenc. Their work appears in journals such as New England Journal of Medicine, The Lancet and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.